Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Advanced Screening Technologies for Target Validation & Identification

Online Symposium

23 October 2024 | Online, BST (UTC+1)

Bringing together key opinion leaders from across the globe for focused discussions on using the latest screening technologies in drug discovery

Register Now Download Agenda Sponsor Opportunities
Online Symposiums Hero Banner Image

Key Topics Covered

  • Fragment screening platforms
  • CRISPR screening
  • Phenotypic screening
  • Target-based
  • Virtual & structure-based approaches
  • Advanced cell screening

Benefits of Attending

  • Meet with global key innovators in a focused symposium to hear the latest case studies in utilizing advanced screening approaches for drug target identification & validation. This programme takes a deep dive into best practice screening approaches & technological advancements, bringing together thought leaders from across the globe for focused discussions & networking
  • Stay at the forefront of innovation by hearing about the latest advancements, cutting-edge techniques, and emerging trends in fragment-based and CRISPR screening approaches used to identify and validate novel drug targets
  • Discuss the latest developments in improved cell screening platforms to advance drug discovery efforts and virtual & structure-based approaches to screening
  • Followed by the release of the ‘Harnessing Advanced Screening Approaches for Drug Target Identification & Validation’ report detailing key insights, methodologies, and emerging trends discussed during the event for leveraging drug discovery screening approaches effectively 



Latest Resources

Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA

A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
Read More

New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease

Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
Read More

The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research

Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Read More

Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition

Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Read More

Abcam: Cancer Biomarkers Guide

Read More

Merck: Analyte Quarterly

Read More

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Discovery Europe 2024: 22 - 23 May 2024, Basel, Switzerland

Berengere Dumotierd
Associate Director,
NOVARTIS
Davide Gianni
senior director,
Astrazeneca
Geoffrey Kerchner
Vice President,
F. Hoffmann-La Roche, Ltd.
Irene Choi
Head of Drug Discovery,
Verge Genomics
Janet Brownlees
Senior Director,
Merck Sharpe and Dohme
Johan Luthman
Executive Vice President of Research & Development,
Lundbeck
Sanne Glad
Scientific Director,
Amgen Research Copenhagen
Show More Speakers
Hide Speakers

All Speakers

Amelie Joffrin
Investigator,
GSK
Anna Vulpetti
Associate Director,
Novartis
Arianna Sabò
Head of Research & Development,
QUANTRO Therapeutics
Ashutosh Dhingra
Staff Scientist,
German Center for Neurodegenerative Diseases
Borislav Dejanovic
Senior Director,
Vigil Neuroscience
Carl Poelking
Associate Director,
Astex
Channabasavaiah Gurumurthy
Director,
University of Nebraska Medical Center
Daohong Zhou
Professor,
UTHSA
David Bearss
Chief Executive Officer,
Halia Therapeutics
Diana Zindel
Associate Director,
AstraZeneca
Eileen Wegner
Research Associate,
NMI Reutlingen
Emma Davies
Associate Director - Preclinical,
Healx
Eric Goedken
Senior Principal Scientist,
AbbVie
Filip Roudnicky
Senior Principal Scientist,
Roche
Gebhard Thoma
Associate Director,
Novartis
Gergely Toth
Chief Executive Officer & Chief Scientific Officer,
Cantabio Pharmaceuticals
Giovanni Spagnolli
Chief Technology Officer,
Sibylla Biotech
Graham Dempsey
Chief Scientific Officer,
Quiver Bioscience
Gregori Gerebtzoff
Director,
Novartis
Gregory Hollingworth
Director,
Novartis
Hai Rao
professor,
Southern University of Science and Technology
James Overell
Medical Director,
Roche
Jon Lea
Team Leader,
GSK
Jonathan Mason
Senior Research Fellow,
Sosei Heptares
Jose Luis Molinuevo
Vice President Head of Experimental Medicine,
H. Lundbeck A/S
Julian Röwe
Senior Scientist,
AbbVie
Kerstin Hofer
Senior Scientist,
Roche
Ludovic Collin
Head of Neuroimmunology,
Roche
Manuel Stritt
Head Scientific Computing Drug Discovery,
Idorsia Pharmaceuticals
Markus Schade
Principal Scientist,
AstraZeneca
Morten Grunnet
Vice President, Head of Neuroscience and Professor,
H. Lundbeck A/S
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
AskBio
Nils Hansen
Chief Executive Officer,
Vipergen
Oliver Hucke
Associate Director,
Boehringer Ingelheim
Olivier Loiseleur
Senior Team Leader,
Syngenta
Olivier Kitten
Founder and Chief Executive Officer,
Affilogic
Olivier Bugaud
Senior Scientist Assay Development & Technologies,
Galapagos
Paulina Kolasinska-Zwierz
Principal Scientist,
Alchemab
Peter Brandt
Head of Chemistry,
Beactica Therapeutics AB
Prashant Gahtori
Professor,
Graphic Era Hill University
Richard Lewis
Director,
Novartis
Robert Fremeau
Chief Executive Officer,
BrainStorm Therapeutics, Inc
Robin Loving
Chief Scientific Officer,
Salipro Biotech AB
Simona Cotesta
Director,
Novartis
Takhar Kasumov
Associate Professor,
Northeastern Ohio University
Tarek Alec Samad
Senior Vice President,
Lundbeck
Ulrike Künzel
Associate Principal Scientist,
Astrazeneca
Urs Langen
Laboratory Head,
Roche
Xinxin Gao
Principal Scientific Manager,
Genentech

Register Your Interest

Submit your details and a member of our team will be in touch